Language

English

Publication Date

8-1-2025

Journal

Digestive Diseases and Sciences

DOI

10.1007/s10620-025-09069-w

PMID

40293634

PMCID

PMC12587488

PubMedCentral® Posted Date

11-6-2025

PubMedCentral® Full Text Version

Author MSS

Abstract

Purpose: Identifying patients likely to develop dysplasia or malignancy is critical for effective surveillance in patients with Barrett's Esophagus (BE). However, current predictive models are limited. We evaluated the performance of machine learning (ML) models in predicting incident dysplasia or malignancy in a cohort of veteran patients with BE.

Methods: We analyzed data from 598 patients newly diagnosed with non-dysplastic BE (NDBE), BE indefinite for dysplasia (BE-IND), and BE with non-persistent low-grade dysplasia (LGD) at the Michael DeBakey Veterans Affairs Medical Center from November 1990 to January 2019 with follow-up through January 2024. Progressors were patients who developed persistent LGD, HGD, or EAC within 5 years of index endoscopy. Six models were evaluated, encompassing regression and ensemble-based ML methods.

Results: Of 598 qualifying patients, 61 (10.2%) progressed. Longer segments and indefinite/non-persistent LGD pathology were associated with higher risk of progression in unadjusted analyses. BE segment length remained significant on multivariate analysis (OR 1.26; 95% CI 1.17-1.36 per 1 cm increase). A decision tree (DT) model, using only segment length, achieved the highest discrimination (AUROC = 0.79) and excellent sensitivity (93.3%). The DT model also identified segment length thresholds for risk stratification: < 0.95 cm (minimal risk), 0.95-2.44 cm (low), 2.44-9.45 cm (moderate), > 9.45 cm (high).

Conclusions: A simple, interpretable DT model with segment length as the sole predictor outperformed regression and complex ML-based models in predicting BE progressors. Findings align with European Society of Gastrointestinal Endoscopy (ESGE) guidelines suggesting tailored surveillance based on segment length and provide actionable thresholds. These results offer a practical ML tool for BE surveillance.

Keywords

Humans, Barrett Esophagus, Machine Learning, Male, Female, Aged, Middle Aged, Esophageal Neoplasms, Adenocarcinoma, Disease Progression, Retrospective Studies, Incidence, Risk Assessment, Predictive Value of Tests, Esophagoscopy, Precancerous Conditions, Barrett’s Esophagus, surveillance, machine learning, clinical risk prediction, endoscopy

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.